News & Updates
Filter by Specialty:
AXS-05 delays relapse of Alzheimer's disease agitation
Treatment with AXS-05 significantly delayed the time to relapse of agitation in patients with Alzheimer’s disease (AD) compared with placebo, according to the phase III ACCORD-2 trial presented at AAN 2025.
AXS-05 delays relapse of Alzheimer's disease agitation
22 Apr 2025
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
Anaemia affects 52.4 percent, while iron deficiency is present in 20.7 percent of Hong Kong patients with advanced prostate cancer (CaP), according to findings from a local cohort.
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
22 Apr 2025
Transnasal cooling a promising drug-free approach to tackling acute migraine attacks
An investigational neuromodulation device that delivers a controlled flow of dry, room-temperature air through the nasal passage helps relieve migraine pain, as shown in a study.
Transnasal cooling a promising drug-free approach to tackling acute migraine attacks
21 Apr 2025
Fremanezumab helps prevent episodic migraine in youths
The use of fremanezumab is safe and effective for the prevention of episodic migraine (EM) in children and adolescents as young as 6 years old, according to a study presented at AAN 2025.